Salesforce put out a polished demo. It showed AI booking your doctor's visits.
The patients in the video still get the same touch-tone phone tree everyone else does. The gap between the pitch and what is live is the whole investor fight right now.
The Demo And The Reality
A promo video showed University of Chicago Medicine patients using Agentforce. That is the firm's top AI agent product.
In the clip, patients refilled scripts and set up visits. They even asked about parking.
Salesforce has been showing the clip to buyers as proof its AI plan is working. The lived experience is different.
Callers to the hospital still get keypad menus. They get routed to human schedulers.
The chatbot is in testing. It is hidden from most web visitors.
Bloomberg called the scenes "largely aspirational." Buyers are trying to figure out how far that is from really deployed.
That gap is more than a marketing problem. It is the whole reason the stock sits where it does.
Market Briefs covers the stories Wall Street is actually trading on each morning - in five minutes, with a free investing masterclass thrown in when you sign up.
Why The Stock Is Down 28%
In February, about $285 billion in value got wiped out of SaaS stocks. The press dubbed it the SaaSpocalypse.
The trigger was simple. Buyers began to worry that AI agents could kill the per-seat pricing model.
That model built Salesforce. CEO Marc Benioff has spent months pushing back.
He has called the SaaSpocalypse overblown. He said Salesforce swatted aside the threat with one of its best quarters ever.
The numbers back parts of his case. The stock chart does not.
Shares are down 28% so far this year. Wall Street is trying to decide which version of the future is right.
In Benioff's version, AI makes Salesforce more useful. Agents drive more work into the platform.
In the bear version, AI eats Salesforce from the inside. Customers build agents on top of cheaper tools and stop paying per seat.
Both can sound right at the same time. That is why the stock keeps swinging.
Worth Watching
The thing buyers care about is the gap between marketing slides and live use. The demos are getting better.
The roll-outs are slower than the demos make them look. The next two earnings calls should tell us which one is catching up.
Watch the count Salesforce reports for Agentforce in real use, not pilot. That one line is the cleanest read.
It tells you if the AI story is real revenue or just a stock price story.
The other thing to watch is pricing. Salesforce has hinted at moving to a "consumption" model.
That means charging by how much the AI actually does, not by seat. A clean shift to that model would soften the per-seat threat.
A slow one keeps the SaaSpocalypse worry alive. The rest of SaaS is watching the same question.
If Salesforce can show real Agentforce revenue, the whole group catches a bid. If it cannot, the 28% drop in the stock will look like just the start.
If you want a daily read on stocks like this in plain English, join the 350,000+ investors reading Market Briefs. You get the newsletter every weekday plus a free 45-minute investing course as a bonus.
